Foster Delivery Science Doubles Laboratory Space and Increases Testing Capabilities

Foster Delivery Science’s expanded space and capabilities will allow for faster turnaround times and grow of testing activities.

Putnam, CT (– DATE –) – Foster Delivery Science, a market leading pharmaceutical contract development and manufacturing organization (CDMO), has doubled the size of their laboratory space and increased their analytical testing capabilities to accommodate their customers’ needs.

The laboratory space for Foster Delivery Science was expanded to double the size from 660 sq. ft (61 sq. meters) to 1,300 sq. ft (121 sq. meters); an additional 375 sq. ft (35 sq. meters) of lab office space was to accommodate the new personnel needed to support the expansion and added capacity are already in the works.

According to David Vario, Vice President of Quality and Regulatory at Foster Delivery Science, “When we planned the expansion, we listened to our customers’ feedback regarding increasing our capabilities. Based on this input, we added dissolution, stability chambers, and total organic carbon (TOC) testing.”

“This expansion will also enable Foster Delivery Science to reduce cleanroom turnaround times, as we won’t need external services, allowing our customers to get the results they are looking for in less time,” said Vario.  “We have already added a new analytical chemist and, as we increase testing for our customers, we will continue to assess the inclusion of additional resources. All of this allows us to continue on our growth trajectory as we continue to add value to our offering.”  For more information about Foster Delivery Science and our capabilities, please visit www.deliveryscience.com.

About Foster Delivery Science
Foster Delivery Science specializes in hot melt extrusion of drugs and polymer for pharmaceutical and combination drug-device applications. The company’s cGMP facility is equipped with state-of-the-art melt extrusion equipment to support pharmaceutical clients from small scale proof of concept to formulation development through clinical supplies and commercial manufacturing. Foster’s equipment inventory includes downstream processing equipment and post extrusion equipment to manufacture most dosage forms.